BCL2 interacting protein 3 pseudogene 35 (BNIP3P35)

BCL2 interacting protein 3 pseudogene 35 (BNIP3P35) is classified as a pseudogene rather than a protein-coding gene. It is related to the BCL2 apoptotic pathway family but does not encode a functional protein. Pseudogenes, including BNIP3P35, do not have therapeutic relevance as direct drug targets, receptors, or enzymes. There is currently no specific biological function, disease involvement, interactions with drugs, or recognized role as a biomarker attributed to BNIP3P35. Its most accurate classification is an unprocessed pseudogene, formally denoted in gene databases and not currently associated with any direct biological or disease role. BNIP3P35 is sometimes confused with the functional gene BCL2 interacting protein 3 (BNIP3). However, BNIP3P35 itself is not a protein-coding gene, does not code for a receptor, enzyme, or related therapeutic target protein. Not to be confused with functional homologs or paralogs involved in apoptosis (such as BNIP3); those have disease and function associations, but BNIP3P35 does not. If the intent was to find a druggable or biologically active target, this entry is incorrect as BNIP3P35 is a pseudogene and not suitable for those purposes. There are other related pseudogenes in the family (e.g., BNIP3P1), but no evidence supports functional peptide production or biomarker status for BNIP3P35. In summary, BNIP3P35 is a pseudogene with no protein product, function, or direct disease relevance, and it is not considered a therapeutic or biological target in current biomedical research.

Other names

BCL2/adenovirus E1B 19kDa interacting protein 3 pseudogene 35BNIP3P35